Global Peter Drucker Forum’s Post

Opportunity Alert!! Pleased to announce a Call for Chapters for our upcoming edited book "Powering Industry 5.0 and Sustainable Development Through Innovation" to be published by IGI Global, USA. We invite you to contribute your expertise and insights. For submission guidelines and further details, please refer to the attachment below. #CallForChapters #EditedBook #ResearchOpportunity #Collaboration #academiccommunity

Industry 4.0 is a convergence of operational, informational, and engineering technologies that were not possible a decade ago. This book is a fresh approach for asset-intensive organizations that provides a roadmap for success. https://lnkd.in/gXthrqH6 #booksworthreading #continuousimprovement #continuouslearning #industry40 Gail Petersen - CRL, MIAM, Sandra DiMatteo, Jacob D Lund, Jack Lucy

📢 Seeking Industry Voices for Two NISO Webinar Panels in August 2024! We are looking for speakers for two upcoming NISO webinar panels: 📚 Strategies & Partnerships: Insights to Build Collaborative Collections, Part One 📅 Date: Wednesday, August 14, 2024 ⏰ Time: 11:00 am – 12:00 pm ET 📚 Managing & Sustaining Collaborative Collections, Part Two 📅 Date: Wednesday, August 21, 2024 ⏰ Time: 11:00 am – 12:00 pm ET Join us as we explore collaborative collection development, focusing on effective strategies, case studies, and sustainability. This is your opportunity to share your insights and experiences on navigating the intricacies of library-publisher collaborations. Speaker Participation: The panels will feature 1-hour roundtable discussions. We ask speakers to join 15-20 minutes before the start. Slides are optional. Additionally, there will be a Speaker Briefing Call to review logistics and key discussion topics. If you're a leader in the field with valuable insights, we want to hear from you! Help shape these important discussions. 📩 Interested? Let us know your availability by sending Kimberly Gladfelter Graham or me a DM. Take Care, Rusty Michalak On behalf of NISO

February Book Review: Start with Why, Simon Sinek Why is MedSTAT in business? What is our heart, mission, and purpose. This past month I finished reading Start with Why, by Simon Sinek. I realized at MedSTAT, we are very clear about what we do, and arguably more clear about how we do it, but I would like to share more about WHY we do what we do here at MedSTAT. My goal for the year is to make it very clear with our partners, customers, and others when they think of MedSTAT, they think of WHY we are in business.

The graft and craft of individual-level open innovation #openinnovation offers great potential for #organizations to tap into the pool of #ideas outside their organization. Yet, it is not straightforward for individual #employees to help their organizations realize that potential. In this book chapter in the Oxford Handbook of #Innovation (Oxford University Press), my coauthors Ammon Salter, Paola Criscuolo and I talk about the critical role of #technologyscouts, #gatekeepers and #innovationchampions (among others). We explain how these individuals can best build the #knowledge and #networks ("graft") and #skills and #workpractices (“craft”) they need to succeed in their role. You can access the chapter here: https://lnkd.in/e8XXKV5S Thanks Henry Chesbrough, Agnieszka Radziwon and Wim Vanhaverbeke for putting such a great collection of articles together in this handbook!

pdf Organizational Innovation and Change: Managing Information and Technology Cecilia Rossignoli, Mauro Gatti, Rocco Agrifoglio (eds.) digsell This book explores a range of critical issues and emerging topics relevant to the linkages between information technologies and organizational systems. It encourages debate and opens up new avenues of inquiry in the fields of Information Systems, organization and management studies by investigating selected themes of growing research interest from multiple disciplinary perspectives such as organizational innovation and impact, information technology, innovation transfer, and knowledge management. The volume is divided into two sections, each of which focuses on a specific theme: ICT, organizational innovation and change; and ICT and knowledge management. The content of each section is based on a … Read More » https://lnkd.in/exmTjjyR

Rapidly evolving markets in Life Sciences are causing companies to take their best shot at adapting commercial models for competitive gain. 🏹 With government pricing pressures and the constant need for new, revenue-driving products, agility, and speed to market are non-negotiable. Getting the commercial policy framework right should not be a shot in the dark! 🎯 Discover how commercial policies can be your guiding light. Read our latest eBook on commercial policies: vistex.link/3tn #LifeSciences #CommercialPolicies #RevenueManagement

While traditional HCI provides advantages for corporations, it can be expensive, isn't always powerful enough, and doesn't address all performance needs. Enter HCI 2.0 from HPE. Check out this eBook, courtesy of TD SYNNEX to learn what this next generation of HCI can do to help your company thrive in our new workplace normal.

Read-worthy post on how to deal with disagreement in research co-production👇 by Gary Hickey- food for thought for anyone in patients' engagement in research. I do agree on the emphasis on people (as in 'disagree with argumentation or opinion but protect the person behind it'). I actually don't agree on the take that disagreement is something problematic, especially not in research- I mean, the entire point of stakeholder engagement is to get a *different* perspective, so if it were all just hunky dory happy agreement all the time, surely that would mean we are missing the point of the entire exercise? Also, in research- you know very well who your real friends are: they will trash your research proposal and send you your manuscript back with 100s of comments- to make sure you look your best going outside. Someone going 'oh that's perfect'- that's actually not a good sign... The entire point of patient or citizen engagement in research is to make research better and more relevant for society- so everyone should actually expect patients to take a keen eye and a sharp pen to any research proposal. And some of that might be valid and some of it might be not- that's where discussion is needed. And especially we as patient organisations should always know the point when to walk. These interactions- you can name them co-productions all you want- but they are rarely truly equal which leaves us with a high risk of co-option: us no real influence on the final say but our name used to endorse the product. Which is why....know your stuff, argue your case, lean into disagreement (but by all means, go for a beer with the people afterwards because bad intent is actually incredibly rare....)- but do walk if the end result is something that violates your key principles. MPNEurope

🔧 Processes may not be glamorous, but they’re vital to success. Trial and error can slow progress and complicate things over time. Keep your team engaged and your initiatives on track by revisiting and refining your processes regularly. Our VCT process aims to streamline the initial phases, ensuring you don't fall into this trap. Discover more insights in the book, Value Creation Technology, authored by RPT's founder, Jeff Eiben. 📚 Check it out here: https://hubs.li/Q02JJZQt0 #ProcessImprovement #Efficiency #RedefinePossible #VCT #ValueCreationTechnology